CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride

NCT00968812 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1452

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Glimepiride
DRUG: Canagliflozin (JNJ-28431754)
DRUG: Metformin

Sponsor

Janssen Research & Development, LLC